Viking Therapeutics (VKTX) Amortizatization of Intangibles (2014 - 2026)

Viking Therapeutics (VKTX) has 10 years of Amortizatization of Intangibles data on file, last reported at $1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Amortizatization of Intangibles fell 58.73% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $7.4 million (down 57.65% YoY), and the FY2025 full-year result was $9.3 million, down 46.23% from the prior year.
• Amortizatization of Intangibles declined to $1.3 million in Q1 2026, from $1.7 million in the prior quarter.
• In the past five years, Amortizatization of Intangibles ranged from a high of $5.4 million in Q2 2024 to a low of $389000.0 in Q1 2023.
• A 4-year average of $2.8 million and a median of $2.7 million in 2023 frame the typical range for Amortizatization of Intangibles.
• Across the five-year window, Amortizatization of Intangibles soared 625.19% in 2024 and plunged 59.25% in 2025, its largest moves.
• Tracing VKTX's Amortizatization of Intangibles over 4 years: stood at $2.7 million in 2023, then jumped by 49.19% to $4.0 million in 2024, then sank by 57.06% to $1.7 million in 2025, then fell by 25.3% to $1.3 million in 2026.
• Business Quant data shows VKTX's Amortizatization of Intangibles at $1.3 million in Q1 2026, $1.7 million in Q4 2025, and $2.0 million in Q3 2025.